RT @ericdeinmd: #EULAR2022 POS0235: Filgotinib Safety in RA for Median 2.2 years: â¶ï¸No new safety concerns from 2020
Tweet Content
#EULAR2022 POS0235: Filgotinib Safety in RA for Median 2.2 years:
▶️No new safety concerns from 2020 report with shorter f/u
▶️Adverse events stable, or decreased, from early studies
@Rheumnow https://t.co/DO15Tqim4n
Show on Archive Page
On
Display in Search Results
On
PDQ
Off